Qualitative and quantitative assessment of accelerated liver diffusion-weighted imaging using deep-learning reconstruction in oncologic patients

利用深度学习重建技术对肿瘤患者加速肝脏扩散加权成像进行定性和定量评估

阅读:1

Abstract

BACKGROUND: Deep-learning (DL) reconstructions could improve image quality and reduce acquisition time in diffusion-weighted imaging (DWI). This study assessed, qualitatively and quantitatively, DL-DWI in liver metastasis of colorectal cancer patients. METHODS: This prospective study enrolled 50 participants from June to November 2022. Phantom and participant data were acquired on a 1.5T MR scanner using a free-breathing DL-DWI research application sequence. Three DWIs were compared: a moderately-accelerated DL-DWI (DL-1), a corresponding standard reconstruction (Standard-1) and a highly-accelerated DL-DWI (DL-2). Image quality (four features on b750 images and one feature on ADC map) was assessed by two radiologists. Region of interest (ROI) based ADC measurements were performed at three locations: liver, spleen, liver metastasis. Across the three series, median scores and ADC values were assessed using a Friedman non-parametric test and post-hoc analysis (pairwise Wilcoxon tests with Bonferroni correction). A p-value < 0.05 was considered statistically significant. RESULTS: Fifty participants with metastatic colorectal cancer (mean age 62 years, range 36-88 years, 26 males) were evaluated. ROIs were delineated in liver (N = 50), spleen (N = 48), and liver metastasis (N = 11). Qualitatively, across both readers, DL-1 method received the highest scores for 5/8 features on the b750 images; all methods scored similarly on ADC maps for both readers. Quantitatively, ADCs were significantly different between DL-1 and Standard-1 series across all three organs, with DL-1-based ADC always higher (p < 0.01). This ADC increase was small: 8.9% (liver), 3.4% (spleen), 4.5% (liver metastasis). CONCLUSIONS: This study suggests that a DL-based reconstruction is a promising technique to enable acceleration of liver DWI considering both qualitative and quantitative results. TRIAL REGISTRATION: NCT05118555 (Evaluation of New Magnetic Resonance Techniques); study date of registration (first submitted: 2021-10-18).

特别声明

1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。

2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。

3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。

4、投稿及合作请联系:info@biocloudy.com。